PATENT CLAIM ANALYSIS

Application Number: 16198121
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "756000"]

Abstract:
This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a  Bacopa monnieri  extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.

Claim (Index 8):
A composition comprising:\n (a) at least about 0.01 mg of an acetylcholinesterase inhibitor, (b) at least one of acetyl-L-carnitine and acetyl CoA, (c) at least about 25 mg of  Bacopa monnieri,  (d) at least about 10 mg of a curcuminoid, (e) at least about 10 IU of Vitamin E, and (f) at least about 0.1 mg of folic acid.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.40625
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14986846', '13693563', '12027652', '12080189', '14453861']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6956251753039518
- 35 USC 102 Novelty (BERT): 0.512457103284579
- Combined Prediction Score: 0.6773083681020146
- Mean Citation Score: 192.8859
- Max Citation Score: 324.4502
- Similarity Product: 314.0634406819344

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test